Search Images Maps Play YouTube Gmail Drive Calendar More »
Settings | Sign in

schizophrenia

Clozapine Best Antipsychotic for Schizophrenia?

Medscape - ‎Jul 21, 2016‎
Not all antipsychotics are equally effective in new users with schizophrenia, a real-world, observational, comparative analysis from Canada confirms.

Adjunctive raloxifene improves outcomes in women with refractory schizophrenia

Healio - ‎21 hours ago‎
Raloxifene hydrochloride, a selective estrogen receptor modulator with mixed agonist and antagonist activity, reduced illness severity and increased likelihood of clinical response in women with treatment-resistant schizophrenia, according to recent ...

People with schizophrenia open up about what it's like living with the condition

Metro - ‎Jul 14, 2016‎
Schizophrenia affects around 1 in 100 people, with it being one of the most common serious mental health conditions. Both men and woman are affected equally, and usually receive the diagnosis between the ages of 15 and 35.

Shedding light on the role of the immune system in schizophrenia

Drug Target Review - ‎Jul 20, 2016‎
Schizophrenia is one of the most common serious mental health conditions. According to the NHS, about 1 in 100 people will experience schizophrenia in their lifetime. It had been suspected that the illness was an autoimmune disorder but the scientists ...

Is schizophrenia a disorder of the immune system?

Science Daily - ‎Jul 19, 2016‎
They conclude that schizophrenia does not appear to be an autoimmune disease and that the illness could be caused by environmental risk factors which activate the immune response, like infections or stress ,although further research is needed.

Evista Blunts Symptoms in Women With Schizophrenia

MedPage Today - ‎Jul 21, 2016‎
The selective estrogen receptor modulator raloxifene (Evista) reduced illness severity in women with refractory schizophrenia, researchers reported. In a 56-patient randomized controlled trial, those given raloxifene had a greater reduction in the ...

Pathological Basis for Deficient Excitatory Drive to Cortical Parvalbumin Interneurons in Schizophrenia

Psychiatric News - ‎Jul 22, 2016‎
Mean density of VGlut1+/PSD95+ puncta on PV+ neurons was 18% lower in schizophrenia, a significant difference. This deficit was not influenced by methodological confounds or schizophrenia-associated comorbid factors, not present in monkeys chronically ...

The Worst Part Of Schizophrenia Isn't What You Think It Is

BuzzFeed News - ‎Jul 17, 2016‎
Hallucinations and delusions may be the public face of schizophrenia, but the hidden cognitive symptoms - which include difficulty focusing on mental tasks, understanding speech, and remembering what just happened - make it very hard for people with ...

Long-acting schizophrenia drug could reduce relapses

The Province - ‎Jul 21, 2016‎
The approval of a new, very long-acting schizophrenia medication by Health Canada could encourage more patients to use injectable drugs that reduce relapses, according to a leading psychiatrist.

Treating High BP Key to Improved Cognition in Schizophrenia?

Medscape - ‎Jul 15, 2016‎
The finding provides support for the role of metabolic abnormalities in the generalized neurocognitive deficits seen in patients with schizophrenia and also suggests that treatment of hypertension may help alleviate cognitive deficits in these patients ...

Schizophrenia drug makes tics less severe in children with Tourrette's

UPI.com - ‎Jul 21, 2016‎
WASHINGTON, July 21 (UPI) -- A drug used to treat schizophrenia is also effective at reducing tics in children with Tourette's disorder, according to a recent analysis of studies.

Do People With Schizophrenia Really Have Multiple Personalities?

Live Science - ‎Jul 13, 2016‎
For people with schizophrenia, it can be difficult to determine what is real and what isn't. This chronic mental disorder is characterized by hallucinations and delusions - false beliefs, hearing voices and seeing things, among other abnormal ...

This is What it's Like to Live With Paranoid Schizophrenia

The Good Men Project - ‎Jul 18, 2016‎
This is What it's Like to Live With Paranoid Schizophrenia. Artist Kevin Nordstrom opens up about learning to live and love and realize he isn't alone.

Identification of Schizophrenia Risk Factors Using Advanced Genetic Analyses at Harvard Medical School

SelectScience.net (press release) (registration) - ‎Jul 20, 2016‎
Steven McCarroll, Associate Professor in the Department of Genetics at Harvard Medical School, USA and colleagues, recently published a study in Nature that reported an association of the major histocompatibility complex (MHC) locus with schizophrenia ...

Patients With Schizophrenia Often Discharged on Multiple Medications

MedicalResearch.com (blog) - ‎Jul 21, 2016‎
Response: Despite the lack of empirical evidence that antipsychotic polypharmacy produces greater outcomes to antipsychotic monotherapy, and that several clinical guidelines recommend against it, patients with a diagnosis of schizophrenia continue to ...

There's Hope For People Living With Schizophrenia

Huffington Post Canada - ‎Jul 18, 2016‎
While the understanding of schizophrenia as a brain disorder has grown significantly within the last 40 years, most people living with this illness do not choose to disclose it.

Study compares aripiprazole and quetiapine for treatment of schizophrenia

News-Medical.net - ‎Jul 15, 2016‎
Schizophrenia is a common cause of incapacity and is ranked as the third-most-disabling illness subsequent to dementia and quadriplegia.
See realtime coverage

Massive breakthrough: Cause of autism, schizophrenia discovered

Morning Ticker - ‎Jul 16, 2016‎
The scientists found that our immune system can greatly affect or even change social behavior, which may have broad implications for how we approach the treatment of neurological diseases like autism and schizophrenia, according to a University of ...

A comparison between quetiapine and aripiprazole for treatment of schizophrenia

EurekAlert (press release) - ‎Jul 13, 2016‎
Nearly, 75% of persons with schizophrenia have continuing problems with recurrent psychotic episodes. Antipsychotics are effective in both the acute and chronic (maintenance) treatment of schizophrenia and other psychotic disorders. They differ in ...

Immersive Virtual Reality Shows Promise for Paranoia in Schizophrenics

iMedicalApps - ‎Jul 19, 2016‎
Schizophrenia with paranoid features, such as persecutory delusions, can be a crippling illness. Various interventions including medications and psychotherapy but can be plagued by problems with side effects and accessibility respectively.
 -